TransMarker: Unveiling dynamic network biomarkers in cancer progression through cross-state graph alignment and optimal transport

The identification of state specific biomarkers that reflect dynamic changes in gene regulatory networks is critical for understanding cancer progression and enhancing diagnostic precision. While multilayer network models have been proposed for analyzing disease evolution, most existing methods rely solely on topological features, neglecting structural rewiring and expression variability across disease states. In this study, we introduce TransMarker, a framework designed to detect genes with regulatory role transitions, those with meaningful shifts in regulatory roles during disease progression, as dynamic biomarkers via cross-state alignment of multi-state single-cell data. TransMarker encodes each disease state as a distinct layer in a multilayer graph, integrating prior interaction data with state-specific expression to construct attributed gene networks. Contextualized embeddings for each stage are generated for each state using Graph Attention Networks (GATs), and structural shifts are quantified via Gromov-Wasserstein optimal transport. Genes with significant changes are ranked using a Dynamic Network Index (DNI), which captures their regulatory variability. These prioritized biomarkers are then applied in a deep neural network for disease state classification. We validate our approach on synthetic simulated and real world dataset of gastric adenocarcinoma (GAC), to evaluate performance across diverse scenarios and assess generalizability. TransMarker outperforms existing multilayer network ranking techniques in classification accuracy, robustness, and biomarker relevance. Ablation studies confirm the contribution of each step to overall performance. Our findings suggest that combining regulatory rewiring, temporal expression dynamics, and cross-state alignment provides a powerful strategy for identifying biologically meaningful biomarkers and modeling disease progression at single cell resolution.

Authors

Institutions

Publication Details

Journal
PLoS Computational Biology
Published
2025-11-24
DOI
https://doi.org/10.1371/journal.pcbi.1013743
Primary Topic
Bioinformatics and Genomic Networks
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

TransMarker: Unveiling dynamic network biomarkers in cancer progression through cross-state graph alignment and optimal transport

Zhi‐Ping Liu, Chuanyuan Wang, Zhixia Yang, Fatemeh Keikha
PLoS Computational Biology
Bioinformatics and Genomic Networks
article

TransMarker: Unveiling dynamic network biomarkers in cancer progression through cross-state graph alignment and optimal transport

Zhi‐Ping Liu, Chuanyuan Wang, Zhixia Yang, Fatemeh Keikha
article en

Abstract

The identification of state specific biomarkers that reflect dynamic changes in gene regulatory networks is critical for understanding cancer progression and enhancing diagnostic precision. While multilayer network models have been proposed for analyzing disease evolution, most existing methods rely solely on topological features, neglecting structural rewiring and expression variability across disease states. In this study, we introduce TransMarker, a framework designed to detect genes with regulatory role transitions, those with meaningful shifts in regulatory roles during disease progression, as dynamic biomarkers via cross-state alignment of multi-state single-cell data. TransMarker encodes each disease state as a distinct layer in a multilayer graph, integrating prior interaction data with state-specific expression to construct attributed gene networks. Contextualized embeddings for each stage are generated for each state using Graph Attention Networks (GATs), and structural shifts are quantified via Gromov-Wasserstein optimal transport. Genes with significant changes are ranked using a Dynamic Network Index (DNI), which captures their regulatory variability. These prioritized biomarkers are then applied in a deep neural network for disease state classification. We validate our approach on synthetic simulated and real world dataset of gastric adenocarcinoma (GAC), to evaluate performance across diverse scenarios and assess generalizability. TransMarker outperforms existing multilayer network ranking techniques in classification accuracy, robustness, and biomarker relevance. Ablation studies confirm the contribution of each step to overall performance. Our findings suggest that combining regulatory rewiring, temporal expression dynamics, and cross-state alignment provides a powerful strategy for identifying biologically meaningful biomarkers and modeling disease progression at single cell resolution.

PLoS Computational BiologyVol. 21(11)
Shandong University (CN), Xinjiang University (CN)
Openalex Percentile: Top 67%
Bioinformatics and Genomic Networks
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.